Abstract
E1101, a new oral caphalosporin, has a (N, N-dimethylcarbamoyloxy)methyl group at the C-3 position of the cephem nucleus. The previous methods for manufacturing 3-(N, N-disubstituted carbamoyloxy)methyl cephems generate various amounts of intractable Δ2 isomers as by-products. In this report, we describe a new, practical synthetic method for cephems of this type without generating Δ2 isomers, via 7-acylamino-3-(4-nitrophenoxy-carbonyloxy)methyl-Δ3-cephem-4-carboxylic acid (5) as a key intermediate.